4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-17-029537
Chief Executive Officer acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2017-12-21 | Option exercise | +15,000 | $1.81 | $27,150 | 148,560 | D |
| Derivatives | |||||||
| Kulkarni Samarth Chief Executive Officer | 2017-12-21 | Option exercise · Employee Stock Option (right to buy) | −15,000 | 279,558 | D | ||
Loading xslF345X03/doc4.xml…